Tyra Biosciences raises $126M via block sale of 4M shares at $31.50 each

Tyra Biosciences, Inc.

Sold 4M common shares at $31.50/share to a large investment management firm for $126M gross proceeds.
Block trade executed under existing ATM program registered on Form S-3; no public offering discount disclosed.
Net proceeds after fees and expenses are undisclosed; use of proceeds not specified in the filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.